News Summary

Proton Intelligence, a Canada-based startup, is making strides in the field of potassium monitoring, which is crucial for individuals with chronic kidney disease or those at risk of heart failure. The startup has successfully closed a $6.95 million seed round led by SOSV, with additional investments from We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor, and Trampoline Venture Partners. Proton is developing a continuous potassium monitoring device that is inserted under the skin, connecting to a smartphone app to help patients track their potassium levels and receive alerts. The device aims to prevent life-threatening complications due to potassium imbalances, a significant concern for patients. The company was co-founded by Sahan Ranamukhaarachchi and Victor Cadarso, who have backgrounds in wearable biosensors and micro- and nano-sensors. Proton’s technology is positioned as scalable and user-friendly, potentially offering greater clinical impact than its competitors. Clinical trials for the product are currently underway, with a market launch anticipated in 2025.